全世界每年有3～5亿的疟疾患者,其中90%发生在非洲。长期以来,在非洲广泛应用并被认为是抗疟特效药的盐酸间苯二酚奎宁(Quinimax),其用量越来越大。而另一种抗疟药青蒿素(Arteminin)对各种疟原虫红内期无性体具有强力杀灭作用,能有效缓解症状和杀灭疟原虫,但青蒿素在尼日尔的市场占有率非常低。为提高对该药的 Between 350 and 500 million malaria patients in the world each year, 90% of which occur in Africa. Quinimax hydrochloride, widely used in Africa and regarded as an anti-malarial drug, has been used in larger and larger doses. Arteminin, another antimalarial drug, has a potent killing effect on various red heritable clones of Plasmodium, which can effectively relieve symptoms and kill Plasmodium, but the market share of artemisinin in Niger is very high low. For improving the medicine